AGP Executive Report
Last update: 8 hours agoDrug Reimbursement Update: Canada’s Drug Agency (CDA-AMC) recommends reimbursing Yorvipath® (palopegteriparatide) with conditions for eligible adults with chronic hypoparathyroidism, a step toward broader public coverage. Long-Term Care Pressure: Quebec data shows 726 hospitalized patients waiting for long-term care beds as of Aug. 3, up from 568 in 2023–24, raising patient-rights concerns. Food Safety: The CFIA recalls Coaticook aged cheddar cheese over possible listeria contamination, urging high-risk groups to discard it. Illicit Drug Alert (NWT): A new benzodiazepine, ethylflualprazolam, has been found in seized drugs; officials warn it can cause severe, long-lasting sedation and isn’t reversed by naloxone. Cybersecurity & Health Data Risk: FBI and investigators are probing how 150M+ U.S. and Canadian IDs (including medical IDs) appeared on the dark web, with links to an ID verification firm. Overdose Calls: Paramedics in Hastings-Quinte report a concerning rise in suspected overdoses, though not yet overwhelming services. Wildfire Threat to Dialysis: McGill research maps wildfire risk to dialysis facilities, flagging communities where disruptions could endanger thousands of patients. MAID Court Ruling (Ontario): An Ontario court denied emergency MAID access for a Toronto woman with bipolar disorder. Beluga Deaths (Canada-U.S. link): Shedd Aquarium reports two more beluga deaths, including one recently rescued from Ontario’s Marineland, with necropsies underway.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.